This protocol is judged by an institutional evaluation board, an unbiased team that reviews any medical trials involving individuals. If a study includes a Routine I drug, after the board approves the protocol as ethical, the scientists have to apply for an investigational new drug (IND) variety with the FDA.Due to this fact, medications in many c